Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRHgh versus Norditropin in children with growth hormone deficiency
IRCT201206054794N5Phase 3Completed
- Sponsor
- Darou Pakhsh
- Start
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Darou Pakhsh. Started Oct 2012; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on IRCT201206054794N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206054794N5.